BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27378131)

  • 21. Short motif sequences determine the targets of the prokaryotic CRISPR defence system.
    Mojica FJM; Díez-Villaseñor C; García-Martínez J; Almendros C
    Microbiology (Reading); 2009 Mar; 155(Pt 3):733-740. PubMed ID: 19246744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinformatics analyses of Shigella CRISPR structure and spacer classification.
    Wang P; Zhang B; Duan G; Wang Y; Hong L; Wang L; Guo X; Xi Y; Yang H
    World J Microbiol Biotechnol; 2016 Mar; 32(3):38. PubMed ID: 26867599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli.
    Sapranauskas R; Gasiunas G; Fremaux C; Barrangou R; Horvath P; Siksnys V
    Nucleic Acids Res; 2011 Nov; 39(21):9275-82. PubMed ID: 21813460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequences spanning the leader-repeat junction mediate CRISPR adaptation to phage in Streptococcus thermophilus.
    Wei Y; Chesne MT; Terns RM; Terns MP
    Nucleic Acids Res; 2015 Feb; 43(3):1749-58. PubMed ID: 25589547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a novel lytic bacteriophage from an industrial Escherichia coli fermentation process and elimination of virulence using a heterologous CRISPR-Cas9 system.
    Halter MC; Zahn JA
    J Ind Microbiol Biotechnol; 2018 Mar; 45(3):153-163. PubMed ID: 29411201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of CRISPR in Streptococcus mutans suggests frequent occurrence of acquired immunity against infection by M102-like bacteriophages.
    van der Ploeg JR
    Microbiology (Reading); 2009 Jun; 155(Pt 6):1966-1976. PubMed ID: 19383692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detecting natural adaptation of the Streptococcus thermophilus CRISPR-Cas systems in research and classroom settings.
    Hynes AP; Lemay ML; Trudel L; Deveau H; Frenette M; Tremblay DM; Moineau S
    Nat Protoc; 2017 Mar; 12(3):547-565. PubMed ID: 28207002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR-based screening of genomic island excision events in bacteria.
    Selle K; Klaenhammer TR; Barrangou R
    Proc Natl Acad Sci U S A; 2015 Jun; 112(26):8076-81. PubMed ID: 26080436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin.
    Bolotin A; Quinquis B; Sorokin A; Ehrlich SD
    Microbiology (Reading); 2005 Aug; 151(Pt 8):2551-2561. PubMed ID: 16079334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Spacer and Protospacer Sequence Requirements in the Vibrio cholerae Type I-E CRISPR/Cas System.
    Bourgeois J; Lazinski DW; Camilli A
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33208517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phage mutations in response to CRISPR diversification in a bacterial population.
    Sun CL; Barrangou R; Thomas BC; Horvath P; Fremaux C; Banfield JF
    Environ Microbiol; 2013 Feb; 15(2):463-70. PubMed ID: 23057534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cas4 Nucleases Define the PAM, Length, and Orientation of DNA Fragments Integrated at CRISPR Loci.
    Shiimori M; Garrett SC; Graveley BR; Terns MP
    Mol Cell; 2018 Jun; 70(5):814-824.e6. PubMed ID: 29883605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPRTarget: bioinformatic prediction and analysis of crRNA targets.
    Biswas A; Gagnon JN; Brouns SJ; Fineran PC; Brown CM
    RNA Biol; 2013 May; 10(5):817-27. PubMed ID: 23492433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR-Cas and restriction-modification systems are compatible and increase phage resistance.
    Dupuis MÈ; Villion M; Magadán AH; Moineau S
    Nat Commun; 2013; 4():2087. PubMed ID: 23820428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ectopic Spacer Acquisition in
    Achigar R; Scarrone M; Rousseau GM; Philippe C; Machado F; Duvós V; Campot MP; Dion MB; Shao Y; Pianzzola MJ; Moineau S
    Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33804420
    [No Abstract]   [Full Text] [Related]  

  • 36. Characterization of CRISPR-Cas systems in the Ralstonia solanacearum species complex.
    da Silva Xavier A; de Almeida JCF; de Melo AG; Rousseau GM; Tremblay DM; de Rezende RR; Moineau S; Alfenas-Zerbini P
    Mol Plant Pathol; 2019 Feb; 20(2):223-239. PubMed ID: 30251378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection and analysis of CRISPRs of Shigella.
    Guo X; Wang Y; Duan G; Xue Z; Wang L; Wang P; Qiu S; Xi Y; Yang H
    Curr Microbiol; 2015 Jan; 70(1):85-90. PubMed ID: 25199561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Avoidance of Trinucleotide Corresponding to Consensus Protospacer Adjacent Motif Controls the Efficiency of Prespacer Selection during Primed Adaptation.
    Musharova O; Vyhovskyi D; Medvedeva S; Guzina J; Zhitnyuk Y; Djordjevic M; Severinov K; Savitskaya E
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro reconstitution of Cascade-mediated CRISPR immunity in Streptococcus thermophilus.
    Sinkunas T; Gasiunas G; Waghmare SP; Dickman MJ; Barrangou R; Horvath P; Siksnys V
    EMBO J; 2013 Feb; 32(3):385-94. PubMed ID: 23334296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-throughput analysis of type I-E CRISPR/Cas spacer acquisition in E. coli.
    Savitskaya E; Semenova E; Dedkov V; Metlitskaya A; Severinov K
    RNA Biol; 2013 May; 10(5):716-25. PubMed ID: 23619643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.